Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI — Stella

Recruiting

Back to Ischemic Cardiovascular Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Russia

NMRCCardiologyRu, Moscow

Key details

Sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Enrollment target

~100 participants

Started

February 2023

Primary completion

February 2028

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov